In vivo genome editing for inherited retinal disease: Opportunities and challenges.
Molecular therapy : the journal of the American Society of Gene Therapy, 32(8): 2433-2434 PMID 39084223 DOI 10.1016/j.ymthe.2024.07.001
Abstract
This article has no abstract in PubMed.